Roche halts study on experimental cancer drug MetMab

* Roche says a committee recommended it halt studies of drug * Roche evaluating what study means for drug's development * Analysts await breast cancer studies for Kadcyla, Perjeta ZURICH, March 3 (Reuters) – Roche Holding AG (Other OTC: RHHBF – news) has halted a study of an experimental lung cancer drug because it failed to help patients with the disease, a blow for the drug which had been seen …
world drug news – Yahoo News Search Results

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us